Skip to main content
. 2017 Mar 20;19:60. doi: 10.1186/s13075-017-1271-7

Fig. 3.

Fig. 3

Soluble endothelial biomarker concentrations in patients with systemic sclerosis (SSc) compared with healthy control subjects (HC). a Vascular endothelial growth factor (VEGF). b Endothelin-1. c Soluble fractalkine (s-Fractalkine). d Correlation between s-Fractalkine and CD34+CD45 endothelial progenitor cell (EPC) counts (nb). Correlation was established using the non-parametric Spearman’s correlation coefficient (r s). * P < 0.05; *** P < 0.0005. n.s = non-significant